SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 127 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $169,000 | -41.5% | 133,429 | +0.6% | 0.00% | -100.0% |
Q3 2021 | $289,000 | -41.6% | 132,648 | +0.5% | 0.00% | 0.0% |
Q2 2021 | $495,000 | +26.6% | 132,043 | +10.2% | 0.00% | 0.0% |
Q1 2021 | $391,000 | -50.6% | 119,870 | -48.4% | 0.00% | -50.0% |
Q4 2020 | $792,000 | -16.4% | 232,093 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $947,000 | -3.0% | 232,093 | -19.6% | 0.00% | 0.0% |
Q2 2020 | $976,000 | +45.7% | 288,708 | +0.5% | 0.00% | +50.0% |
Q1 2020 | $670,000 | +104.9% | 287,300 | +219.4% | 0.00% | +100.0% |
Q4 2019 | $327,000 | -56.0% | 89,955 | +0.3% | 0.00% | -50.0% |
Q3 2019 | $744,000 | +4.3% | 89,670 | +8.3% | 0.00% | 0.0% |
Q2 2019 | $713,000 | -14.1% | 82,765 | +6.6% | 0.00% | -33.3% |
Q1 2019 | $830,000 | +32.6% | 77,626 | +8.4% | 0.00% | +50.0% |
Q4 2018 | $626,000 | -43.0% | 71,594 | +9.5% | 0.00% | -33.3% |
Q3 2018 | $1,098,000 | -18.5% | 65,366 | +1.7% | 0.00% | -25.0% |
Q2 2018 | $1,347,000 | +41.9% | 64,243 | +8.9% | 0.00% | +33.3% |
Q1 2018 | $949,000 | -15.3% | 59,009 | -0.2% | 0.00% | -25.0% |
Q4 2017 | $1,120,000 | +71.3% | 59,111 | +27.2% | 0.00% | +100.0% |
Q3 2017 | $654,000 | +105.7% | 46,480 | +8.9% | 0.00% | +100.0% |
Q2 2017 | $318,000 | +20.0% | 42,680 | +4.6% | 0.00% | 0.0% |
Q1 2017 | $265,000 | +58.7% | 40,790 | +8.5% | 0.00% | 0.0% |
Q4 2016 | $167,000 | 0.0% | 37,600 | +5.4% | 0.00% | 0.0% |
Q3 2016 | $167,000 | -15.7% | 35,670 | +18.2% | 0.00% | 0.0% |
Q2 2016 | $198,000 | +17.9% | 30,190 | +14.1% | 0.00% | 0.0% |
Q1 2016 | $168,000 | +10.5% | 26,460 | +4.9% | 0.00% | 0.0% |
Q4 2015 | $152,000 | -86.9% | 25,220 | -87.0% | 0.00% | -83.3% |
Q3 2015 | $1,157,000 | -11.1% | 193,460 | +1.7% | 0.01% | -14.3% |
Q2 2015 | $1,301,000 | +14.2% | 190,270 | +1.4% | 0.01% | +16.7% |
Q1 2015 | $1,139,000 | -10.6% | 187,590 | +2.1% | 0.01% | -14.3% |
Q4 2014 | $1,274,000 | -19.8% | 183,800 | -5.8% | 0.01% | -22.2% |
Q3 2014 | $1,588,000 | +11.6% | 195,100 | +11.5% | 0.01% | +12.5% |
Q2 2014 | $1,423,000 | +812.2% | 175,050 | +777.4% | 0.01% | +700.0% |
Q1 2014 | $156,000 | -9.8% | 19,950 | +1.8% | 0.00% | 0.0% |
Q4 2013 | $173,000 | -88.8% | 19,600 | -89.4% | 0.00% | -90.0% |
Q3 2013 | $1,548,000 | -38.0% | 184,800 | -44.8% | 0.01% | -37.5% |
Q2 2013 | $2,498,000 | – | 334,800 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |